Deutsch English Français

Contact

EP2543383

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2543383

EP2543383 - Macrocyclic compounds and methods of treatment [Right-click to bookmark this link]
Status	The application has been withdrawn Status updated on 05.08.2016 Database last updated on 06.11.2024
Most recent event Tooltip	05.08.2016	Withdrawal of application	published on 07.09.2016 [2016/36]
Applicant(s)	For all designated states University of Florida Research Foundation, Inc. P.O. Box 115500 Gainesville Florida 32611-5500 / US
	[2013/02]
Inventor(s)	01 / Luesch, Hendrik 8433 Sw 21st Lane Gainesville, FL Florida 32607 / US
	02 / Paul, Valerie 309 St. Lucie Lane Fort Pierce, FL Florida 34946 / US
	03 / Taori, Kanchan 702 Sw 16th Avenue 205 Gainesville, FL Florida 32601 / US
	[2013/02]
Representative(s)	Helbig, Christian Wagner + Helbig Patentanwälte Pfarrstrasse 14 80538 München / DE
	[2013/02]
Application number, filing date	12181107.9	09.09.2008
	[2013/02]
Priority number, date	US20070970986P	09.09.2007 Original published format: US 970986 P
	US20080009903P	03.01.2008 Original published format: US 9903 P
	US20080030993P	24.02.2008 Original published format: US 30993 P
	US20080125542P	24.04.2008 Original published format: US 125542 P
	US20080189093P	15.08.2008 Original published format: US 189093 P
	[2013/02]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2543383
	Date:	09.01.2013
	Language:	EN
	[2013/02]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	06.12.2012
Classification	IPC:	A61K45/06, A61K31/429, C07D513/14, C07D513/18, A61K38/00	[2016/04]
	CPC:	C07D513/14 (EP,US); A61K31/429 (EP,US); A61K45/06 (US); A61P17/06 (EP); A61P21/00 (EP); A61P25/00 (EP); (+) A61P25/14 (EP); A61P25/28 (EP); A61P29/00 (EP); A61P31/12 (EP); A61P33/02 (EP); A61P35/00 (EP); A61P43/00 (EP); A61P9/00 (EP); C07D513/18 (EP,US); A61K38/00 (EP,US) (-)
	Former IPC [2013/02]	A61K38/00, C07K16/18, A61P35/00, A61P29/00, A61P31/00, A61P33/00, A61P25/00, C07D513/18
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2013/02]
Title	German:	Makrocyclische Verbindungen und Behandlungsverfahren	[2013/02]
	English:	Macrocyclic compounds and methods of treatment	[2013/02]
	French:	Composés macrocycliques et procédés de traitement	[2013/02]
Examination procedure	20.08.2012	Examination requested [2013/02]
	30.10.2013	Despatch of a communication from the examining division (Time limit: M06)
	25.04.2014	Reply to a communication from the examining division
	13.10.2015	Despatch of a communication from the examining division (Time limit: M02)
	08.12.2015	Reply to a communication from the examining division
	04.02.2016	Communication of intention to grant the patent
	23.05.2016	Fee for grant paid
	23.05.2016	Fee for publishing/printing paid
	23.05.2016	Receipt of the translation of the claim(s)
	22.07.2016	Application withdrawn by applicant [2016/36]
Parent application(s) Tooltip	EP08829476.4 / EP2190449
Fees paid	Renewal fee
	20.08.2012	Renewal fee patent year 03
	20.08.2012	Renewal fee patent year 04
	20.08.2012	Renewal fee patent year 05
	27.09.2013	Renewal fee patent year 06
	29.09.2014	Renewal fee patent year 07
	28.09.2015	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XP] - YING Y ET AL, "Total synthesis and molecular target of largazole, a histone deacetylase inhibitor", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 20080702 AMERICAN CHEMICAL SOCIETY US, (20080702), vol. 130, no. 26, doi:10.1021/JA8013727, pages 8455 - 8459, XP002614057 [XP] 1-10 * page 8455 * DOI: http://dx.doi.org/10.1021/JA8013727
		[XP] - REN Q ET AL, "Total synthesis of largazole", SYNLETT 20080915 DE LNKD- DOI:10.1055/S-2008-1078270, (20080915), no. 15, ISSN 0936-5214, pages 2379 - 2383, XP009142332 [XP] 1-10 * abstract *
		[XP] - TAORI KANCHAN ET AL, "Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (200802), vol. 130, no. 6, ISSN 0002-7863, pages 1806 - 1807, XP002614058 [XP] 1-10 * page 1806 * DOI: http://dx.doi.org/10.1021/JA7110064
	by applicant	- FURUMAI ET AL., CANCER RESEARCH, (2002), vol. 62, pages 4916 - 4921
		- YUREK-GEORGE ET AL., J. MED. CHEM., (2007), vol. 50, pages 5720 - 5726
		- BERGE ET AL., "Pharmaceutical Salts", J PHARM. SCI., (1977), vol. 66, pages 1 - 19
		- JÄHNISCH, K ET AL., ANGEW. CHEM. INT. ED. ENGL., (2004), vol. 43, page 406
		- The Merck Manual of Diagnosis and Therapy, (1987), pages 1206 - 1228
		- BERGE ET AL., JOURNAL OF PHARMACEUTICAL SCIENCE, (1977), vol. 66, pages 1 - 19
		- K. D. PAULL; E. HAMEL; L. MALSPEIS, Cancer Chemotherapeutic Agents, AMERICAN CHEMICAL SOCIETY, (1995), pages 10 - 11
		- WU ET AL., J. AM. CHEM. SOC., (2002), vol. 124, pages 14520 - 14521
		- DING ET AL., PROC. NATL. ACAD. SCI. USA, (2003), vol. 100, pages 7632 - 7637
		- CHEN ET AL., J. AM. CHEM. SOC., (2004), vol. 126, pages 410 - 411
		- KOEHN, F. E.; CARTER, G. T., NAT. REV. DRUG DISCOV., (2005), vol. 4, pages 206 - 220
		- PATERSON, I.; ANDERSON, E. A., SCIENCE, (2005), vol. 310, pages 451 - 453
		- FENICAL, W.; JENSEN, P. R., NAT. CHEM. BIOL., (2006), vol. 2, pages 666 - 673
		- GERWICK, W. H.; TAN, L. T.; SITACHITTA, N., ALKALOIDS CHEM. BIOL., (2001), vol. 57, pages 75 - 184
		- LUESCH, H.; MOORE, R. E.; PAUL, V. J.; MOOBERRY, S. L.; CORBETT, T. H., J. NAT. PROD., (2001), vol. 64, pages 907 - 910
		- GERWICK, W. H.; PROTEAU, P. J.; NAGLE, D. G.; HAMEL, E.; BLOKHIN, A.; SLATE, D. L., J. ORG. CHEM., (1994), vol. 59, pages 1243 - 1245
		- VERDIER-PINARD, P.; LAI, J.-Y.; YOO, H.-D.; YU, J.; MARQUEZ, B.; NAGLE, D. G.; NAMBU, M.; WHITE, J. D.; FALCK, J. R.; GERWICK, W., MOL. PHARMACOL., (1998), vol. 53, pages 62 - 76
		- LUESCH, H.; YOSHIDA, W. Y.; MOORE, R. E.; PAUL, V. J.; CORBETT, T. H., J. AM. CHEM. SOC., (2001), vol. 123, pages 5418 - 5423
		- LUESCH, H.; CHANDA, S. K.; RAYA, M. R.; DEJESUS, P. D.; ORTH, A. P.; WALKER, J. R.; IZPISUA BELMONTE, J. C.; SCHULTZ, P. G., NAT. CHEM. BIOL., (2006), vol. 2, pages 158 - 167
		- CARMELI, S.; MOORE, R. E.; PATTERSON, G. M. L., TETRAHEDRON LETT., (1991), vol. 32, pages 2593 - 2596
		- PATTENDEN, G.; THOM, S. M. J., CHEM. SOC. PERKIN TRANS., vol. 11993, pages 1629 - 1636
		- BOYCE, R. J.; PATTENDEN, G., TETRAHEDRON, (1995), vol. 51, pages 7313 - 7320
		- CARMELI, S.; MOORE, R. E.; PATTERSON, G. M. L., J. AM. CHEM. SOC., (1990), vol. 112, pages 8195 - 8197
		- HORTON, P.; INMAN, W. D.; CREWS, P., J. NAT. PROD., (1990), vol. 53, pages 143 - 151
		- ROLLER, P.; AU, K.; MOORE, R. E., CHEM. COMMUN., (1971), pages 503 - 504
		- SATA, N.; ABINSAY, H.; YOSHIDA, W. Y.; HORGEN, F. D.; SITACHITTA, N.; KELLY, M.; SCHEUER, P., J. J. NAT. PROD., (2005), vol. 68, pages 1400 - 1403
		- PEREZ BAZ, J.; CANEDO, L. M.; FERNANDEZ, PUENTES, J. L.; SILVA ELIPE, M. V., J. ANTIBIOT. (TOKYO, (1997), vol. 50, pages 738 - 741
		- BOGER, D. G.; ICHIKAWA, S., J. AM. CHEM. SOC., (2000), vol. 122, pages 2956 - 2957

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p